BR112014016896A2 - derivados de heteroarilamida tendo propriedades antiandrogênicas - Google Patents
derivados de heteroarilamida tendo propriedades antiandrogênicasInfo
- Publication number
- BR112014016896A2 BR112014016896A2 BR112014016896A BR112014016896A BR112014016896A2 BR 112014016896 A2 BR112014016896 A2 BR 112014016896A2 BR 112014016896 A BR112014016896 A BR 112014016896A BR 112014016896 A BR112014016896 A BR 112014016896A BR 112014016896 A2 BR112014016896 A2 BR 112014016896A2
- Authority
- BR
- Brazil
- Prior art keywords
- antiandrogenic properties
- amide derivatives
- heteroaryl amide
- formula
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
resumo patente de invenção: "derivados de heteroarilamida tendo propriedades antiandrogênicas". a presente invenção refere-se a novos derivados de heteroarilamida possuindo a fórmula (i) (i) e n-óxidos, estereoisômeros e seus sais farmaceuticamente aceitáveis, em que ra, rb, r11, r', r'', z e x são tal como definidos nas reivindicações. os derivados de arilamida de fórmula (i) possuem propriedades antiandrogênicas. a invenção também se refere a compostos de fórmula (i) para uso como um medicamento e a composições farmacêuticas que os compreendem e a sua preparação.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20125039 | 2012-01-13 | ||
| FI20125039 | 2012-01-13 | ||
| PCT/FI2013/050027 WO2013104830A1 (en) | 2012-01-13 | 2013-01-11 | Novel heteroarylamide derivatives having antiandrogenic properties |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112014016896A2 true BR112014016896A2 (pt) | 2017-06-13 |
| BR112014016896A8 BR112014016896A8 (pt) | 2017-07-04 |
| BR112014016896B1 BR112014016896B1 (pt) | 2021-08-17 |
Family
ID=47683784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014016896-2A BR112014016896B1 (pt) | 2012-01-13 | 2013-01-11 | Derivados de heteroarilamida tendo propriedades antiandrogênicas, seus processos de preparação e composições farmacêuticas |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9650382B2 (pt) |
| EP (1) | EP2802563B1 (pt) |
| JP (1) | JP6234376B2 (pt) |
| KR (1) | KR102058886B1 (pt) |
| CN (1) | CN104066717B (pt) |
| AR (1) | AR089702A1 (pt) |
| AU (1) | AU2013208847B2 (pt) |
| BR (1) | BR112014016896B1 (pt) |
| CA (1) | CA2861713C (pt) |
| DK (1) | DK2802563T3 (pt) |
| EA (1) | EA029007B1 (pt) |
| ES (1) | ES2640119T3 (pt) |
| HK (1) | HK1201838A1 (pt) |
| MX (1) | MX356499B (pt) |
| NZ (1) | NZ626715A (pt) |
| PL (1) | PL2802563T3 (pt) |
| SG (1) | SG11201404053RA (pt) |
| TW (1) | TWI635080B (pt) |
| WO (1) | WO2013104830A1 (pt) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
| JP4255381B2 (ja) | 2001-12-13 | 2009-04-15 | 住友化学株式会社 | ビカルタミドの結晶およびその製造方法 |
| US7741371B2 (en) | 2002-06-17 | 2010-06-22 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
| AU2003286757B2 (en) | 2002-11-01 | 2009-06-04 | Merck Sharp & Dohme Corp. | Carbonylamino-benzimidazole derivatives as androgen receptor modulators |
| AU2007275737A1 (en) | 2006-07-19 | 2008-01-24 | Osurf | Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| US8461343B2 (en) | 2007-03-27 | 2013-06-11 | Sloan-Kettering Institute For Cancer Research | Synthesis of thiohydantoins |
| DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
| ITBO20090078A1 (it) | 2009-02-13 | 2010-08-14 | Consiglio Nazionale Ricerche | Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi |
| EP2424853B1 (en) | 2009-04-10 | 2018-09-19 | Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (I.R.S.T.) S.R.L. | Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof |
| SI3124481T1 (en) | 2010-02-16 | 2018-06-29 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and their use |
| FR2982261B1 (fr) | 2011-11-04 | 2014-06-13 | Galderma Res & Dev | Nouveaux amides, et leur utilisation pharmaceutique ou cosmetique |
-
2013
- 2013-01-11 AR ARP130100090A patent/AR089702A1/es active IP Right Grant
- 2013-01-11 AU AU2013208847A patent/AU2013208847B2/en active Active
- 2013-01-11 DK DK13703633.1T patent/DK2802563T3/en active
- 2013-01-11 TW TW102101023A patent/TWI635080B/zh active
- 2013-01-11 SG SG11201404053RA patent/SG11201404053RA/en unknown
- 2013-01-11 CA CA2861713A patent/CA2861713C/en active Active
- 2013-01-11 ES ES13703633.1T patent/ES2640119T3/es active Active
- 2013-01-11 NZ NZ626715A patent/NZ626715A/en unknown
- 2013-01-11 BR BR112014016896-2A patent/BR112014016896B1/pt active IP Right Grant
- 2013-01-11 WO PCT/FI2013/050027 patent/WO2013104830A1/en active Application Filing
- 2013-01-11 EP EP13703633.1A patent/EP2802563B1/en active Active
- 2013-01-11 KR KR1020147022538A patent/KR102058886B1/ko active IP Right Grant
- 2013-01-11 JP JP2014551659A patent/JP6234376B2/ja active Active
- 2013-01-11 PL PL13703633T patent/PL2802563T3/pl unknown
- 2013-01-11 CN CN201380005365.7A patent/CN104066717B/zh active Active
- 2013-01-11 US US14/371,927 patent/US9650382B2/en active Active
- 2013-01-11 MX MX2014008524A patent/MX356499B/es active IP Right Grant
- 2013-01-11 EA EA201491364A patent/EA029007B1/ru not_active IP Right Cessation
-
2015
- 2015-03-10 HK HK15102462.8A patent/HK1201838A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6234376B2 (ja) | 2017-11-22 |
| EA201491364A1 (ru) | 2014-11-28 |
| AU2013208847A1 (en) | 2014-08-14 |
| ES2640119T3 (es) | 2017-10-31 |
| MX356499B (es) | 2018-05-30 |
| KR20140117531A (ko) | 2014-10-07 |
| KR102058886B1 (ko) | 2019-12-24 |
| WO2013104830A1 (en) | 2013-07-18 |
| HK1201838A1 (en) | 2015-09-11 |
| CA2861713A1 (en) | 2013-07-18 |
| TW201332974A (zh) | 2013-08-16 |
| PL2802563T3 (pl) | 2017-11-30 |
| US9650382B2 (en) | 2017-05-16 |
| EA029007B1 (ru) | 2018-01-31 |
| BR112014016896A8 (pt) | 2017-07-04 |
| AR089702A1 (es) | 2014-09-10 |
| NZ626715A (en) | 2016-07-29 |
| TWI635080B (zh) | 2018-09-11 |
| CN104066717B (zh) | 2019-07-30 |
| SG11201404053RA (en) | 2014-10-30 |
| BR112014016896B1 (pt) | 2021-08-17 |
| CN104066717A (zh) | 2014-09-24 |
| EP2802563B1 (en) | 2017-06-07 |
| CA2861713C (en) | 2021-08-31 |
| US20150005308A1 (en) | 2015-01-01 |
| DK2802563T3 (en) | 2017-09-18 |
| JP2015504892A (ja) | 2015-02-16 |
| AU2013208847B2 (en) | 2017-08-31 |
| EP2802563A1 (en) | 2014-11-19 |
| MX2014008524A (es) | 2014-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020003055A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| BR112015014222A2 (pt) | composto, composição farmacêutica, uso de um composto, método para o tratamento de anemia e composição farmacêutica | |
| UY32174A (es) | Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones | |
| GEP201706698B (en) | Inhibitors of influenza viruses replication | |
| NZ735575A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
| EA201390008A1 (ru) | Новые ариламидные производные, обладающие антиандрогенными свойствами | |
| PH12014502540B1 (en) | Benzimidazole-proline derivatives | |
| NZ732391A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
| UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
| BR112014011162A2 (pt) | derivados purínicos para o tratamento de infecções virais | |
| BR112015019590A2 (pt) | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv | |
| CY1111442T1 (el) | Ενωσεις πιπεριδινης και χρησεις αυτων | |
| BR112014001083B8 (pt) | Composto, processo para a preparação de um composto, composição farmacêutica, uso da composiçâo farmacêutica e uso do composto | |
| MX2010013310A (es) | Derivados de heterociclil urea para el tratamiento de infecciones bacterianas. | |
| WO2015002755A3 (en) | Compounds for the treatment of malaria | |
| BR112012006233B8 (pt) | composto de fórmula i, composição farmacêutica e usos de um composto | |
| BR112014016896A8 (pt) | derivados de heteroarilamida tendo propriedades antiandrogênicas | |
| BR112013028197A2 (pt) | compostos de benzofurano-piperidina | |
| BR112015031827A2 (pt) | composto, processo para preparação de um composto, composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/01/2013, OBSERVADAS AS CONDICOES LEGAIS. |